Published in Nucleic Acids Res on April 11, 1993
Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J (1994) 2.33
The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc Natl Acad Sci U S A (1993) 1.63
Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter. Mol Cell Biol (2002) 1.44
Restricted expression of E2A protein in primary human tissues correlates with proliferation and differentiation. Am J Pathol (1998) 0.98
Substitution of basic amino acids in the basic region stabilizes DNA binding by E12 homodimers. Nucleic Acids Res (1996) 0.87
E2A suppresses invasion and migration by targeting YAP in colorectal cancer cells. J Transl Med (2013) 0.84
The bHLH factors extramacrochaetae and daughterless control cell cycle in Drosophila imaginal discs through the transcriptional regulation of the Cdc25 phosphatase string. PLoS Genet (2014) 0.82
The E47 transcription factor binds to the enhancer sequences of recombinant murine leukemia viruses and influences enhancer function. J Virol (1995) 0.78
Discovering multiple realistic TFBS motifs based on a generalized model. BMC Bioinformatics (2009) 0.77
Embryonic expression and evolution of duplicated E-protein genes in Xenopus laevis: parallels with ancestral E-protein genes. Genetics (1997) 0.77
A novel initiator regulates expression of the nontissue-specific helix-loop-helix gene ME1. Nucleic Acids Res (1995) 0.76
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73
Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell (1987) 22.17
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science (1985) 9.73
Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science (1990) 9.54
The myoD gene family: nodal point during specification of the muscle cell lineage. Science (1991) 9.53
Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements. Science (1985) 8.44
Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell (1989) 8.42
Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science (1987) 7.63
MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell (1989) 6.94
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell (1991) 6.48
A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J (1989) 6.37
Assembly of the mitochondrial membrane system. CBP6, a yeast nuclear gene necessary for synthesis of cytochrome b. J Biol Chem (1985) 6.32
A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev (1989) 5.91
A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell (1990) 5.39
Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science (1990) 4.93
An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell (1991) 4.80
Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev (1989) 4.50
Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci U S A (1988) 4.19
daughterless, a Drosophila gene essential for both neurogenesis and sex determination, has sequence similarities to myc and the achaete-scute complex. Cell (1988) 3.94
Cell-type-specific contacts to immunoglobulin enhancers in nuclei. Nature (1985) 3.94
A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc Natl Acad Sci U S A (1987) 3.08
Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci U S A (1981) 2.96
HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol Cell Biol (1992) 2.72
Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev (1990) 2.46
B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol Cell Biol (1991) 2.28
Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev (1991) 2.22
Pancreatic beta-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins. Mol Cell Biol (1991) 2.04
Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer. Mol Endocrinol (1991) 2.03
A beta-cell-specific protein binds to the two major regulatory sequences of the insulin gene enhancer. Proc Natl Acad Sci U S A (1988) 2.00
Pancreatic beta-cell-type-specific expression of the rat insulin II gene is controlled by positive and negative cellular transcriptional elements. Mol Cell Biol (1989) 1.89
Cell-specific and ubiquitous factors are responsible for the enhancer activity of the rat insulin II gene. J Biol Chem (1991) 1.82
Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: implications for B-lymphoid-cell development. Mol Cell Biol (1991) 1.80
Individual protein-binding domains of the insulin gene enhancer positively activate beta-cell-specific transcription. Mol Cell Biol (1989) 1.61
Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription. Immunol Today (1992) 1.58
Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene (1991) 1.56
Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes. Nucleic Acids Res (1991) 1.51
A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res (1990) 1.49
Subunit structure of cell-specific E box-binding proteins analyzed by quantitation of electrophoretic mobility shift. J Biol Chem (1992) 1.17
The chymotrypsin enhancer core. Specific factor binding and biological activity. J Biol Chem (1989) 1.12
B-cell factor 1 is required for optimal expression of the DRA promoter in B cells. Mol Cell Biol (1992) 0.88
Characterization of the binding of alpha-bungarotoxin to bacterially expressed cholinergic binding sites. J Biol Chem (1988) 0.85
Cell-specific expression controlled by the 5'-flanking region of insulin and chymotrypsin genes. Nature (1984) 8.65
Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements. Science (1985) 8.44
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21
Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA (2000) 7.25
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci U S A (1986) 6.57
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med (1980) 4.90
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg (1978) 4.55
Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA (2000) 4.41
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature (1992) 3.49
Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med (1996) 3.16
A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc Natl Acad Sci U S A (1987) 3.08
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med (1999) 2.81
Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature (1991) 2.60
Regulation of rat insulin 1 gene expression: evidence for negative regulation in nonpancreatic cells. Proc Natl Acad Sci U S A (1986) 2.57
An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys (1979) 2.54
Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell (1983) 2.54
Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem (1994) 2.51
Stroke: who's counting what? J Rehabil Res Dev (2001) 2.32
Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol (2000) 2.29
Effects of a worksite nonsmoking policy: evidence for increased cessation. Am J Public Health (1991) 2.27
Detection and incidence of specific species of spoilage bacteria on fish. II. Relative incidence of Pseudomonas putrefaciens and fluorescent pseudomonads on haddock fillets. Appl Microbiol (1968) 2.27
DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med (1995) 2.25
PRiSM Psychosis Study. Design limitations, questionable conclusions. Br J Psychiatry (1999) 2.17
Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. Am J Obstet Gynecol (1998) 2.08
The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol (1998) 2.07
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 1.97
Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity (1998) 1.88
High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg (1988) 1.87
Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1996) 1.82
Non-Invasive detection of respiratory effort-related arousals (REras) by a nasal cannula/pressure transducer system. Sleep (2000) 1.82
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep (1983) 1.81
Neurotoxicity of commonly used antineoplastic agents (second of two parts). N Engl J Med (1974) 1.77
Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway. J Virol (1998) 1.71
The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc Natl Acad Sci U S A (1993) 1.63
Individual protein-binding domains of the insulin gene enhancer positively activate beta-cell-specific transcription. Mol Cell Biol (1989) 1.61
Superior vena cava syndrome. The myth--the facts. Am Rev Respir Dis (1990) 1.60
The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg (1966) 1.58
Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037). Cancer Res (1971) 1.57
Vibrios from fish pen slime which mimic Escherichia coli on violet red bile agar. Appl Microbiol (1970) 1.57
Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology (2004) 1.55
Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J (1999) 1.52
Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes. Nucleic Acids Res (1991) 1.51
A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res (1990) 1.49
Effect of low intensity monochromatic light therapy (890 nm) on a radiation-impaired, wound-healing model in murine skin. Lasers Surg Med (1998) 1.46
Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation (2000) 1.45
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A (1998) 1.44
Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol (2000) 1.44
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am (1999) 1.42
Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest (2001) 1.40
Practice-related functional activation changes in a working memory task. Microsc Res Tech (2000) 1.38
Brain tubulin and actin cDNA sequences: isolation of recombinant plasmids. Nucleic Acids Res (1980) 1.35
A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effects. Pharmacoeconomics (1998) 1.34
Workplace compliance with a no-smoking law: a randomized community intervention trial. Am J Public Health (1992) 1.30
Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus (1997) 1.28
The Life Skills Profile: psychometric properties of a measure assessing function and disability in schizophrenia. Acta Psychiatr Scand (1991) 1.26
Community orientated treatment compared to psychiatric hospital orientated treatment. Soc Sci Med (1984) 1.24
Neurotoxicity of commonly used antineoplastic agents (first of two parts). N Engl J Med (1974) 1.20
Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter. J Biol Chem (2000) 1.20
Threshold Assessment Grid (TAG): the development of a valid and brief scale to assess the severity of mental illness. Soc Psychiatry Psychiatr Epidemiol (2000) 1.20
A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc Natl Acad Sci U S A (1996) 1.19
The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant (2007) 1.19
Tumor necrosis factor alpha modifies agonist-dependent responses in human neutrophils by inducing the synthesis and myristoylation of a specific protein kinase C substrate. Proc Natl Acad Sci U S A (1990) 1.18
Subunit structure of cell-specific E box-binding proteins analyzed by quantitation of electrophoretic mobility shift. J Biol Chem (1992) 1.17
Atrial fibrillation and antithrombotic prophylaxis: a prospective meta-analysis. Lancet (1989) 1.16
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest (1998) 1.14
Apoptosis in systemic lupus erythematosus. Clinical implications. Rheum Dis Clin North Am (2000) 1.14
The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum (2001) 1.14
Genes and pseudogenes in a reiterated rat tRNA gene cluster. Nucleic Acids Res (1984) 1.13
Clearing the way to mechanisms of autoimmunity. Nat Med (2001) 1.13
Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transpl Immunol (1997) 1.12
Novel fragments of the Sjögren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death. Arthritis Rheum (2001) 1.12
Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ (1992) 1.11
Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett (1996) 1.09
Level of sleepiness and total sleep time following various time in bed conditions. Sleep (1993) 1.08
Lymphogenous metastasis in the primary carcinoma of the fallopian tube. Gynecol Oncol (1994) 1.08
Barium appendicitis: fact or fancy? Report of a case and review of the literature. J Clin Gastroenterol (1987) 1.07
NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. J Autoimmun (1996) 1.07
Smoking reduction during pregnancy by a program of self-help and clinical support. Obstet Gynecol (1992) 1.06
NF-kappa B activates the HIV promoter in neurons. EMBO J (1993) 1.06
Eye examinations for VA patients with diabetes: standardizing performance measures. Int J Qual Health Care (2000) 1.05
"Coffee groups": a nine-year follow-up study. Am J Psychiatry (1980) 1.05
Spontaneous rupture of the urinary bladder--delayed sequel of pelvic irradiation. A case report. S Afr Med J (1986) 1.04
(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor. J Med Chem (2000) 1.04
Functional characterization of mouse T lymphocytes with IgM-Fc receptors. I. Studies on ADCC and helper cell function. J Immunol (1979) 1.04
The inhibition of apoptosis in myositis and in normal muscle cells. J Immunol (2000) 1.03
Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic data. Cancer (1976) 1.03
Granzyme B cleavage of autoantigens in autoimmunity. Cell Death Differ (2010) 1.03
Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation (2001) 1.03
The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest (1997) 1.02
Control of apoptosis by proteases. Adv Pharmacol (1997) 1.00
Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med (1997) 1.00
Eustachian tube endoscopy in patients with chronic ear disease. Laryngoscope (2000) 0.99
mRNA for the rat uterine estrogen-induced protein. Translation in vitro and regulation by estrogen. J Biol Chem (1981) 0.99
Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J Biol Chem (1988) 0.99